Press What’s news at AbelsonTaylor Group
Select category
Cybersecurity considerations in pharma marketing: Trust must come first
“Responsible AI adoption is essential to protecting our clients, our agency, and the patients ultimately served by the work we help bring to life,” writes AbelsonTaylor Group’s Amer Ghafari, vice president of IT operations, in MedAdNews.
Read his thoughts on maintaining trust in pharmaceutical advertising with effective cybersecurity: https://www.pharmalive.com/cybersecurity-considerations-in-pharma-marketing-trust-must-come-first/
Media Contact:
Recent Posts
The missing skill in the AI era isn’t prompting — It’s curiosity
“Curiosity is what builds judgment, and this is why AI is most powerful in the hands of curious people,” according...
In the News Read more The missing skill in the AI era isn’t prompting — It’s curiosityThe biggest barrier to AI adoption in healthcare isn’t regulation. It’s trust.
As AI adoption accelerates, trust may be the real differentiator. In MedAdNews, Janet Barker-Evans, Chief Creative Officer of AbelsonTaylor Group,...
In the News Read more The biggest barrier to AI adoption in healthcare isn’t regulation. It’s trust.From Insights to Action: The Bridge Between Strategy and Execution
“Having access to more information doesn’t automatically lead to better decisions—you need judgment,” says AbelsonTaylor Group’s Amy Restko, VP, Engagement...
In the News Read more From Insights to Action: The Bridge Between Strategy and ExecutionConnect with us
Find out what's top of mind for the people reimagining health and wellness advertising.